MA54510A - Procédé de séchage par pulvérisation de peptide glp-1 - Google Patents

Procédé de séchage par pulvérisation de peptide glp-1

Info

Publication number: MA54510A
Authority: MA; Morocco
Prior art keywords: glp; drying process; spray drying; peptide spray; peptide
Prior art date: 2018-12-21

Application number

MA054510A

Other languages

English (en)

Inventor

Pall Thor Ingvarsson

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-12-21

Filing date

2019-12-20

Publication date

2022-03-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65013488&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA54510(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2019-12-20 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

2022-03-30 Publication of MA54510A publication Critical patent/MA54510A/fr

Links

102100025101 GATA-type zinc finger protein 1 Human genes 0.000 title 1
101710198884 GATA-type zinc finger protein 1 Proteins 0.000 title 1
DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 title 1
238000000034 method Methods 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
238000001694 spray drying Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/184—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D1/00—Evaporating
- B01D1/14—Evaporating with heated gases or vapours or liquids in contact with the liquid
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D1/00—Evaporating
- B01D1/16—Evaporating by spraying
- B01D1/18—Evaporating by spraying to obtain dry solids
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D1/00—Evaporating
- B01D1/16—Evaporating by spraying
- B01D1/20—Sprayers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Zoology (AREA)
Epidemiology (AREA)
Polymers & Plastics (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Obesity (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Animal Husbandry (AREA)
Food Science & Technology (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)

MA054510A 2018-12-21 2019-12-20 Procédé de séchage par pulvérisation de peptide glp-1 MA54510A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP18215348		2018-12-21

Publications (1)

Publication Number	Publication Date
MA54510A true MA54510A (fr)	2022-03-30

Family

ID=65013488

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA054510A MA54510A (fr)	2018-12-21	2019-12-20	Procédé de séchage par pulvérisation de peptide glp-1

Country Status (7)

Country	Link
US (1)	US11617965B2 (fr)
EP (1)	EP3897582B1 (fr)
JP (1)	JP7410952B2 (fr)
CN (1)	CN113194929B (fr)
ES (1)	ES2994462T3 (fr)
MA (1)	MA54510A (fr)
WO (1)	WO2020127950A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP7410952B2 (ja)	2018-12-21	2024-01-10	ノヴォノルディスクアー／エス	Ｇｌｐ－１ペプチドの噴霧乾燥のプロセス
JP7549593B2 (ja) *	2019-03-15	2024-09-11	ノヴォノルディスクアー／エス	Ｇｌｐ－１ペプチドを噴霧乾燥するためのプロセス
CN114191541A (zh) *	2020-09-02	2022-03-18	齐鲁制药有限公司	喷雾冷冻干燥法制备索玛鲁肽微粒
US20240115497A1 (en) *	2021-02-05	2024-04-11	Zhejiang Cuize Pharmaceutical Technology Co., Ltd.	Inhalable pharmaceutical powder formulation and preparation method therefor
KR102849380B1 (ko) *	2022-12-16	2025-08-21	포스코홀딩스 주식회사	황화 리튬의 제조 방법
WO2025133729A1 (fr)	2023-12-18	2025-06-26	Assia Chemical Industries Ltd.	Procédé de préparation de peptides glp-1 et de peptides glp-1/gip doubles ayant une taille de particule contrôlée

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPO637197A0 (en) *	1997-04-23	1997-05-15	F.H. Faulding & Co. Limited	Taste-masked pharmaceutical compositions
US6223455B1 (en)	1999-05-03	2001-05-01	Acusphere, Inc.	Spray drying apparatus and methods of use
WO2001093837A2 (fr)	2000-06-08	2001-12-13	Eli Lilly And Company	Poudre proteinique administree par voie pulmonaire
JP2005506956A (ja) *	2001-06-01	2005-03-10	イーライ・リリー・アンド・カンパニー	長時間作用性ｇｌｐ−１製剤
TWI372629B (en)	2005-03-18	2012-09-21	Novo Nordisk As	Acylated glp-1 compounds
CA2683610C (fr)	2007-04-23	2013-01-08	Intarcia Therapeutics, Inc.	Formulations en suspension de peptides insulinotropes et leurs utilisations
JP5496082B2 (ja) *	2007-04-30	2014-05-21	ノボ・ノルデイスク・エー／エス	タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
US20100183876A1 (en) *	2008-12-23	2010-07-22	Hell Andre	Process for the Preparation of a Peptide Powder Form
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
WO2013103801A1 (fr) *	2012-01-04	2013-07-11	Hospira, Inc.	Séchage par pulvérisation pharmaceutique
EP4324475A1 (fr)	2012-03-22	2024-02-21	Novo Nordisk A/S	Compositions de peptides glp-1 et leur préparation
JP6517690B2 (ja) *	2012-06-20	2019-05-22	ノヴォノルディスクアー／エス	ペプチド及び送達剤を含む錠剤製剤
WO2014144895A1 (fr) *	2013-03-15	2014-09-18	Mannkind Corporation	Compositions de dicétopipérazine microcristallines et procédés
WO2014191545A1 (fr)	2013-05-30	2014-12-04	Novo Nordisk A/S	Composition pharmaceutique orale d'un nouveau type destinée au traitement du diabète
PT107567B (pt)	2014-03-31	2019-02-13	Hovione Farm S A	Secador por atomização com atomizador múltiplo, método para o aumento de escala de pós para inalação secos por dispositivo de atomização múltiplo e uso de vários atomizadores num secador por atomização
CN106924750B (zh)	2015-12-31	2021-03-23	深圳翰宇药业股份有限公司	一种索马鲁肽口服微粒制剂及其制备方法
US12569543B2 (en) *	2016-04-28	2026-03-10	Novo Nordisk A/S	Semaglutide in cardiovascular conditions
JP2019532068A (ja) *	2016-10-13	2019-11-07	カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップＣａｐｓｕｇｅｌＢｅｌｇｉｕｍＮＶ	噴霧乾燥組成物の製造方法及び噴霧乾燥装置
CN108745218A (zh)	2018-06-26	2018-11-06	苏州大学	一种制备多肽微球的装置及方法
JP7410952B2 (ja)	2018-12-21	2024-01-10	ノヴォノルディスクアー／エス	Ｇｌｐ－１ペプチドの噴霧乾燥のプロセス

2019
- 2019-12-20 JP JP2021535869A patent/JP7410952B2/ja active Active
- 2019-12-20 ES ES19828757T patent/ES2994462T3/es active Active
- 2019-12-20 MA MA054510A patent/MA54510A/fr unknown
- 2019-12-20 EP EP19828757.5A patent/EP3897582B1/fr active Active
- 2019-12-20 CN CN201980084815.3A patent/CN113194929B/zh active Active
- 2019-12-20 US US17/415,623 patent/US11617965B2/en active Active
- 2019-12-20 WO PCT/EP2019/086645 patent/WO2020127950A1/fr not_active Ceased

Also Published As

Publication number	Publication date
JP7410952B2 (ja)	2024-01-10
CN113194929A (zh)	2021-07-30
JP2022514893A (ja)	2022-02-16
EP3897582A1 (fr)	2021-10-27
US11617965B2 (en)	2023-04-04
ES2994462T3 (en)	2025-01-24
WO2020127950A1 (fr)	2020-06-25
EP3897582C0 (fr)	2024-09-11
CN113194929B (zh)	2022-12-09
US20220088500A1 (en)	2022-03-24
EP3897582B1 (fr)	2024-09-11

Publication	Publication Date	Title
EP3874215C0 (fr)	2024-01-17	Système de séchage par pulvérisation électrostatique
EP3778621A4 (fr)	2021-06-30	Procédé de synthèse peptidique
DK4155640T3 (da)	2024-07-15	Sprøjtetørrer
IL259690B (en)	2022-10-01	Use of c-type natriuretic peptide variants to treat osteoarthritis
EP3954468C0 (fr)	2024-05-15	Pistolet de pulvérisation
EP4063019A4 (fr)	2022-12-14	Pistolet de pulvérisation
EP3610003A4 (fr)	2021-01-06	Procédé de production de virus recombinant
EP3766984A4 (fr)	2021-05-12	Procédé de détermination
EP3890891C0 (fr)	2024-08-07	Pistolet pulvérisateur de peinture
EP4265992C0 (fr)	2025-10-22	Ensemble buse de séchage par pulvérisation électrostatique
EP3953503C0 (fr)	2025-09-24	Procédé de polissage électrolytique
EP3494806C0 (fr)	2025-08-06	Lacto-n-fucopentaose séché par pulvérisation
EP3979796C0 (fr)	2024-10-09	Dispositif d'application de pulvérisation
EP4382149C0 (fr)	2025-11-19	Pulvérisation nasale bi-dose
JP1711552S (ja)	2022-04-01	スプレーガン
EP3897582C0 (fr)	2024-09-11	Procédé de séchage par pulvérisation de semaglutide
EP3494804C0 (fr)	2025-08-13	3-fucosyllactose séché en pulvérisation
PL3539929T3 (pl)	2025-04-07	Układ do suszenia rozpyłowego
EP3528319A4 (fr)	2019-10-30	Procédé de séchage d'électrode
EP4408590A4 (fr)	2025-08-27	Pistolet de pulvérisation
EP3747582A4 (fr)	2021-11-17	Procédé de brasage
EP4055337C0 (fr)	2024-08-21	Ensemble de buse de flash
EP3493301A4 (fr)	2019-06-26	Procédé de séchage d'électrodes
EP3859007A4 (fr)	2021-11-24	Procédé de détermination
IL285391A (en)	2021-09-30	A process for spray-drying a glp-1 peptide